Significant Ownership of John Raymond Murphy
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for John Raymond Murphy focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- Springfield, MO
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
1 identity field
CIK context first
Continue from John Raymond Murphy
Significant Ownership of John Raymond Murphy
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CVKD | Cadrenal Therapeutics, Inc. | Common Stock, $0.001 par value per share | 3% | $899,164 | 53,205 | John Raymond Murphy | 31 Dec 2024 |
Schedules 13D/G Reported by John Raymond Murphy:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.